| |
| |
|
| Insider
Information: |
Merrifield C Ann |
| Relationship: |
Director |
| City: |
Framingham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
14,967 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,346 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
14,967 |
|
|
| Total
Value |
$1,346 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -65.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pyxus International Inc |
PYX |
Director |
2007-10-01 |
0 |
2007-10-01 |
0 |
Premium* |
|
|
Invivo Therapeutics Holdings Cor... |
NVIV |
Director |
2020-03-10 |
3,639 |
2015-08-12 |
0 |
Premium* |
|
|
Juniper Pharmaceuticals Inc |
JNP |
Director |
2018-08-14 |
0 |
2015-08-13 |
0 |
Premium* |
|
|
Flexion Therapeutics Inc |
FLXN |
Director |
2021-11-19 |
0 |
2015-09-11 |
0 |
Premium* |
|
|
Lyra Therapeutics, Inc. |
LYRA |
Director |
2022-06-10 |
11,328 |
2021-06-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LYRA |
Lyra Therapeutics, Inc. |
Director |
– • – |
2022-06-10 |
4 |
B |
$5.05 |
$20,200 |
D/D |
4,000 |
11,328 |
2.39 |
- |
|
| LYRA |
Lyra Therapeutics, Inc. |
Director |
– • – |
2022-05-16 |
4 |
B |
$5.00 |
$1,640 |
D/D |
328 |
7,328 |
2.31 |
- |
|
| LYRA |
Lyra Therapeutics, Inc. |
Director |
– • – |
2022-05-13 |
4 |
B |
$4.81 |
$16,846 |
D/D |
3,500 |
7,000 |
2.39 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2021-11-19 |
4 |
D |
$8.50 |
$161,500 |
D/D |
(19,000) |
0 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2021-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
19,000 |
0 |
- |
|
| LYRA |
Lyra Therapeutics, Inc. |
Director |
– • – |
2021-06-17 |
4 |
B |
$8.97 |
$31,395 |
D/D |
3,500 |
3,500 |
2.39 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
14,500 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
Director |
– • – |
2020-03-10 |
4 |
B |
$0.00 |
$0 |
D/D |
3,636 |
3,639 |
2.31 |
% |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2019-05-23 |
4 |
B |
$12.64 |
$101,120 |
D/D |
8,000 |
10,000 |
2.39 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
Director |
– • – |
2018-08-14 |
4 |
D |
$11.50 |
$277,185 |
D/D |
(24,103) |
0 |
0 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
Director |
– • – |
2016-08-26 |
4 |
B |
$5.63 |
$11,260 |
D/D |
2,000 |
15,193 |
2.39 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
Director |
– • – |
2016-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,064 |
13,193 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2016-06-14 |
4 |
B |
$13.39 |
$13,387 |
D/D |
1,000 |
2,000 |
2.39 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
Director |
– • – |
2015-12-04 |
4 |
B |
$12.14 |
$19,421 |
D/D |
1,600 |
7,129 |
2.39 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
Director |
– • – |
2015-10-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,529 |
5,529 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2015-09-11 |
4 |
B |
$23.00 |
$23,000 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
Director |
– • – |
2015-08-14 |
4 |
B |
$9.87 |
$19,740 |
D/D |
2,000 |
3,000 |
2.39 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
Director |
– • – |
2015-08-13 |
4 |
B |
$9.96 |
$9,960 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
Director |
– • – |
2015-08-12 |
4 |
B |
$12.36 |
$24,718 |
D/D |
2,000 |
2,000 |
2.39 |
- |
|
| PYX |
Pyxus International Inc |
Director |
– • – |
2007-10-01 |
4 |
D |
$18.30 |
$428,842 |
D/D |
(23,434) |
0 |
0 |
- |
|
| PYX |
Pyxus International Inc |
Director |
– • – |
2007-10-01 |
4 |
D |
$18.30 |
$187,868 |
I/I |
(10,266) |
0 |
0 |
- |
|
| PYX |
Pyxus International Inc |
Director |
– • – |
2007-05-22 |
4 |
OE |
$9.75 |
$87,750 |
D/D |
9,000 |
23,434 |
0 |
- |
|
| PYX |
Pyxus International Inc |
Director |
– • – |
2007-05-01 |
4 |
A |
$15.50 |
$91,450 |
I/I |
5,900 |
5,900 |
0 |
- |
|
| PYX |
Pyxus International Inc |
Director |
– • – |
2006-04-25 |
4 |
A |
$0.01 |
$43 |
D/D |
4,300 |
18,800 |
0 |
- |
|
| PYX |
Pyxus International Inc |
Director |
– • – |
2005-06-14 |
4 |
A |
$0.01 |
$45 |
D/D |
4,500 |
14,500 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
